30 : 60246031 Lappalainen P, Watmough NJ, Greenwood C, Saraste M
It sits at the centre of the comparison between GLP-1 agonists, dual GLP-1/GIP agonists, and newer triple agonist approaches
doi:10.1007/s11011-013-9435-x, PMID: 24557875 Sadowska AM, Manuel-Y-Keenoy B, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review
Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic OPLAH mutations: 20 new mutations in 14 families
GHK-Cu is present in human plasma, saliva, and urine, with concentrations highest during youth and gradually declining with age